BrianBurgessChesebroMD

PubMed

• Development and validation of a model to calculate anesthetic agent consumption from inspired and end-expired concentrations, minute ventilation, fresh gas flow and de...
  Louise Cuveele, Jan F A Hendrickx, Andre M De Wolf, Sofie De Cooman, Brian B Chesebro, Jeffrey Feldman, Jodi Sherman> ;Journal of Clinical Monitoring and Computing. 2023 Feb 1
• 37 citations
  Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans.
  Mitchell J. Cohen, Michel Carles, Karim Brohi, Carolyn S. Calfee, Pamela Rahn, Mariah Call, Brian B. Chesebro, Michael West, Jean-Francois Pittet> ;The Journal of Trauma. 2010 Jun 1
• 32 citations
  Transforming Growth Factor β1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphat...
  Jérémie Roux, Michel Carles, Hidefumi Koh, Arnaud Goolaerts, Michael T. Ganter, Brian B. Chesebro, Marybeth Howard, Benjamin T. Houseman, Walter E. Finkbeiner, Kevan M...> ;The Journal of Biological Chemistry. 2010 Feb 12
• 208 citations
  Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion.
  Mitchell J. Cohen, Karim Brohi, Carolyn S. Calfee, Pamela Rahn, Brian B. Chesebro, Sarah C. Christiaans, Michel Carles, Marybeth Howard, Jean-Francois Pittet> ;Critical Care. 2009 Nov 4
• 28 citations
  Protein C depletion early after trauma increases the risk of ventilator-associated pneumonia.
  Mitchell J. Cohen, Natasha D. Bir, Pamela Rahn, Rachel H. Dotson, Karim Brohi, Brian B. Chesebro, Robert C. Mackersie, Michel Carles, Jeanine P. Wiener-Kronish, Jean-F...> ;The Journal of Trauma. 2009 Dec 1
• 130 citations
  Increase in activated protein C mediates acute traumatic coagulopathy in mice.
  Brian B. Chesebro, Pamela Rahn, Michel Carles, Charles T. Esmon, Jun Xu, Karim Brohi, Daniel Frith, Jean-Francois Pittet, Mitchell J. Cohen> ;Shock. 2009 Dec 1
• 98 citations
  Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?
  Michael T. Ganter, Mitchell J. Cohen, Karim Brohi, Brian B. Chesebro, Kristan Staudenmayer, Pamela Rahn, Sarah C. Christiaans, Natasha D. Bir, Jean-Francois Pittet> ;Annals of Surgery. 2008 Feb 1
• 17 citations
  A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with C...
  Erwin Blessing, Lee Ann Campbell, Michael E. Rosenfeld, Brian Chesebro, C. C. Kuo> ;The Journal of Antimicrobial Chemotherapy. 2005 Jun 1
• 31 citations
  Lesion progression and plaque composition are not altered in older apoE−/− mice lacking tumor necrosis factor-α receptor p55
  Erwin Blessing, Florian Bea, Cho Chou Kuo, Lee Ann Campbell, Brian Chesebro, Michael E. Rosenfeld> ;Atherosclerosis. 2004 Oct 1
• 16 citations
  Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis
  Brian Chesebro, Erwin Blessing, Cho Chou Kuo, Michael E. Rosenfeld, Mirja Puolakkainen, Lee Ann Campbell> ;Cardiovascular Research. 2003 Oct 15
• 33 citations
  Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines.
  Erwin Blessing, Cho Chou Kuo, Tsun-Mei Lin, Lee Ann Campbell, Florian Bea, Brian Chesebro, Michael E. Rosenfeld> ;Circulation. 2002 Apr 23
• N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
  Lawson VA, Priola SA, Wehrly K, Chesebro B> ;J. Biol. Chem.. 2001-09-21
• 34 citations
  A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering.
  Nancy J. Thompson, Edward J. Boyko, Jason A. Dominitz, Donald W. Belcher, Brian B. Chesebro, Linda M. Stephens, Michael K. Chapko> ;Preventive Medicine. 2000 Mar 1
• Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.
  Caughey B, Raymond GJ, Priola SA, Kocisko DA, Race RE, Bessen RA, Lansbury PT, Chesebro B> ;Mol. Biotechnol.. 1999-11-01
• Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.
  Chabry J, Priola SA, Wehrly K, Nishio J, Hope J, Chesebro B> ;J. Virol.. 1999-08-01
• Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides.
  Chabry J, Caughey B, Chesebro B> ;J. Biol. Chem.. 1998-05-22
• Abnormal properties of prion protein with insertional mutations in different cell types.
  Priola SA, Chesebro B> ;J. Biol. Chem.. 1998-05-08
• BSE and Prions: Uncertainties About the Agent
  Brian Chesebro, MD> ;Science Magazine. 1998 Jan 24
• Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie.
  Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MB, Weissmann C, Chesebro B> ;EMBO J.. 1997-10-15
• A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
  Priola SA, Chesebro B> ;J. Virol.. 1995-12-01
• Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent.
  Race RE, Priola SA, Bessen RA, Ernst D, Dockter J, Rall GF, Mucke L, Chesebro B, Oldstone MB> ;Neuron. 1995-11-01
• Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
  Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT, Caughey B> ;Proc. Natl. Acad. Sci. U.S.A.. 1995-04-25
• A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP.
  Priola SA, Caughey B, Wehrly K, Chesebro B> ;J. Biol. Chem.. 1995-02-17
• Cell-free formation of protease-resistant prion protein.
  Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B> ;Nature. 1994-08-11
• Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells.
  Priola SA, Caughey B, Race RE, Chesebro B> ;J. Virol.. 1994-08-01
• Join now to see all